Dr. Amin J. Mirhadi

Get to Know Dr. Amin J. Mirhadi

Radiation oncologist Dr. Amin J. Mirhadi is a key member of the multidisciplinary Mesothelioma Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Center.

The Mesothelioma Program includes immunotherapy clinical trials and early detection testing for disease while emphasizing a personalized approach to treating this rare cancer.

Mirhadi handles the image-guided, precision radiation treatments that are often part of a trimodality regimen leading to extended survival for patients. He works closely with other specialists, including thoracic oncologist Dr. Ani Balmanoukian and thoracic surgeon Dr. Harmik Soukiasian at Cedars-Sinai.

He also treats lung cancer, breast cancer, brain cancer, pineal tumors and spinal meningiomas. Mirhadi is skilled in stereotactic radiosurgery and intensity-modulated radiation therapy.

Specialties of Dr. Amin J. Mirhadi

• Radiation oncology
• Pleural mesothelioma
• Lung cancer
• Brain cancers
• Breast tumors
• Interventional oncology
• Metastatic bone cancers
• Stereotactic radiosurgery

Dr. Amin J. Mirhadi’s Experience and Medical Education

• Cedars-Sinai Samuel Oschin Comprehensive Cancer Center
• University of California, Irvine School of Medicine (M.D.)
• UCLA Medical Center (Residency)
• Santa Barbara Cottage Hospital (Residency)

Awards and Certifications

• Compassion Accolade Rewarding Excellence Award
• ACRO Award for Outstanding Work in Pediatric Radiation Oncology
• Cedars-Sinai Medical Center Leadership Development Course
• Radiation Therapy Oncology Group (Member)
• American Society of Therapeutic Radiology and Oncology (Member)

Publications of Dr. Amin J. Mirhadi

• Anderson, E.M. et al. (2020, August 15). Interstitial high-dose-rate brachytherapy in the treatment of keloids: Moving toward a volumetric approach. Brachytherapy.
• Powell, A. et al. (2020, July). The Association Between Use of Hypofractionation and Treatment Completion Among Recipients of Radiation Therapy Post-Mastectomy. Practical Radiation Oncology.
• Mirhadi, A. et al. (2017, March). Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202. International Journal of Radiation Oncology, Biology and Physics.
• Sandler, H. & Mirhadi, A.J. (2010, June). Current status of radiation therapy for bladder cancer. Expert Review of Anticancer Therapy.